Exactitude_Consultancy_Logo.png
Global Endobronchial Valves Market Expected to Experience Strong Growth by 2031 | Exactitude Consultancy
24 sept. 2024 07h38 HE | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
Supernus Pharmaceuticals, Inc.
Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree
24 sept. 2024 07h30 HE | Supernus Pharmaceuticals, Inc.
Ahead of ADHD Awareness Month, Busy is sharing her ADHD diagnosis and Qelbree® (viloxazine extended-release capsules) treatment story to empower women living with ADHD to advocate for their care.ADHD...
edited logo.jpg
Draganfly Receives Military Purchase Order for its Commander 3XL to be used for logistics within various branches of the U.S. Department of Defense
24 sept. 2024 07h30 HE | Draganfly Inc
Commander 3XL to be used as a primary transport vehicle for the TB2 Aerospace DROPS UAV Cargo POD for autonomous tactical resupply Saskatoon Sask, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc....
Logo Resized for Globe Newswire2.jpg
Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
24 sept. 2024 07h30 HE | Wave Life Sciences USA, Inc.
Mean muscle content-adjusted dystrophin expression of 9.0% and unadjusted dystrophin of 5.5%, with high consistency across participants, in a prespecified analysis; dystrophin was comprised of two...
zevra_inline_fullcolor_rgb_12in@300ppi (1).png
Zevra Therapeutics to Present Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at Sleep Europe 2024
24 sept. 2024 07h30 HE | Zevra Therapeutics
KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study CELEBRATION, Fla., Sept. 24, 2024 ...
Koryx_logo_LR - copie.png
Koryx Copper Appoints CFO and Technical Management Team, Accelerating the Advancement of the Haib Copper Project, Southern Namibia
24 sept. 2024 07h30 HE | Koryx Copper Inc.
VANCOUVER, British Columbia, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Koryx Copper Inc. (“Koryx” or the "Company") (TSX-V: KRY) announces the appointment of a highly experienced technical and management...
Cytokinetics.png
Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
24 sept. 2024 07h30 HE | Cytokinetics, Incorporated
Program to Provide $100,000 in Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is November 4th, 2024 SOUTH SAN...
Hookipa Pharma Logo Square.png
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
24 sept. 2024 07h30 HE | HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a clinical-stage biopharmaceutical company developing next generation...
NCino Logo.png
BankNewport Reports Deposit Account Opening Process Accelerated by as much as Ninety Percent, Streamlining a Key Consumer Banking Experience with nCino
24 sept. 2024 07h30 HE | nCino, Inc.
WILMINGTON, N.C., Sept. 24, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that BankNewport is live on the...
ocugen_4C_LOGO (002).png
Ocugen to Participate in a Fireside Chat at Chardan’s 8th Annual Genetic Medicines Conference
24 sept. 2024 07h30 HE | Ocugen
MALVERN, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...